We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Procept Biorobotics
PRCT
$1.03B
| $1.21M | 0.01% |
29,107
-312
| -1% | -$13.4K |
|
652
Carter Bankshares
CARE
$765M
| $1.2M | 0.01% |
72,422
-579
| -0.8% | -$10.1K |
|
653
Tactile Systems Technology
TCMD
$623M
| $1.2M | 0.01% |
104,224
-40,386
| -28% | -$355K |
|
|
NEUE
654
DELISTED
NeueHealth
NEUE
| $1.2M | 0.01% |
22,986
+20,906
| +1,005% | +$1.52M |
|
655
Valhi
VHI
$394M
| $1.19M | 0.01% |
54,060
-3,111
| -5% | -$75.6K |
|
|
GRTS
656
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $1.18M | 0.01% |
343,348
-812,916
| -70% | -$2.32M |
|
|
GLDD
657
DELISTED
Great Lakes Dredge & Dock
GLDD
| $1.17M | 0.01% |
196,723
+5,261
| +3% | +$37K |
|
658
Akebia Therapeutics
AKBA
$335M
| $1.16M | 0.01% |
2,014,767
-28,049
| -1% | -$8.79K |
|
|
SNV
659
DELISTED
Synovus
SNV
| $1.16M | 0.01% |
30,855
| – | – |
|
660
Financial Institutions
FISI
$828M
| $1.14M | 0.01% |
46,670
-7,698
| -14% | -$189K |
|
661
Atlantic Union Bankshares
AUB
$6.07B
| $1.12M | 0.01% |
31,990
-2,920
| -8% | -$99.8K |
|
|
BASE
662
DELISTED
Couchbase
BASE
| $1.11M | 0.01% |
83,536
-22,108
| -21% | -$286K |
|
|
SRDX
663
DELISTED
Surmodics
SRDX
| $1.11M | 0.01% |
32,448
-7,894
| -20% | -$265K |
|
664
Laureate Education
LAUR
$5.37B
| $1.1M | 0.01% |
114,171
+11,332
| +11% | +$122K |
|
|
ICVX
665
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $1.09M | 0.01% |
137,645
-109,835
| -44% | -$471K |
|
666
Group 1 Automotive
GPI
$4.37B
| $1.09M | 0.01% |
6,059
-82,813
| -93% | -$14.6M |
|
667
Delta Air Lines
DAL
$57.2B
| $1.09M | 0.01% |
33,126
-40,054
| -55% | -$1.33M |
|
|
TSVT
668
DELISTED
2seventy bio
TSVT
| $1.08M | 0.01% |
115,115
+12,047
| +12% | +$170K |
|
669
Byline Bancorp
BY
$1.78B
| $1.07M | 0.01% |
46,435
-3,636
| -7% | -$81.5K |
|
670
Douglas Elliman
DOUG
$158M
| $1.06M | 0.01% |
274,525
+79,439
| +41% | +$317K |
|
671
Avista
AVA
$3.45B
| $1.06M | 0.01% |
23,912
| – | – |
|
672
CytomX Therapeutics
CTMX
$692M
| $1.06M | 0.01% |
661,892
-432,426
| -40% | -$640K |
|
673
Monarch Casino & Resort
MCRI
$2.2B
| $1.05M | 0.01% |
13,609
+9,988
| +276% | +$755K |
|
674
Vera Bradley
VRA
$101M
| $1.05M | 0.01% |
230,942
-103,090
| -31% | -$377K |
|
675
Kimberly-Clark
KMB
$37.4B
| $1.04M | 0.01% |
+7,660
| New | +$973K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.